5大がん+2部位ステージ別治療別登録件数
10.5大がん+2部位ステージ別治療別登録件数(症例区分2.3)
2011-2015 症例区分2.3 cSTAGE<pSTAGE
胃がん
I | II | III | IV | 不明・その他 | 総計 | |
---|---|---|---|---|---|---|
手術のみ | 37 | 8 | 8 | 7 | 0 | 60 |
48.05% | 44.44% | 61.54% | 17.07% | 0.00% | 37.74% | |
内視鏡のみ | 30 | 0 | 0 | 0 | 1 | 31 |
38.96% | 0.00% | 0.00% | 0.00% | 10.00% | 19.50% | |
放射線のみ | 0 | 0 | 0 | 0 | 1 | 1 |
0.00% | 0.00% | 0.00% | 0.00% | 10.00% | 0.63% | |
薬物療法 のみ |
2 | 1 | 1 | 7 | 1 | 12 |
2.60% | 5.56% | 7.69% | 17.07% | 10.00% | 7.55% | |
放射線 +薬物 |
1 | 0 | 0 | 0 | 0 | 1 |
1.30% | 0.00% | 0.00% | 0.00% | 0.00% | 0.63% | |
薬物 +その他 |
1 | 0 | 0 | 2 | 0 | 3 |
1.30% | 0.00% | 0.00% | 4.88% | 0.00% | 1.89% | |
手術/内視鏡 +薬物 |
1 | 7 | 3 | 11 | 0 | 22 |
1.30% | 38.89% | 23.08% | 26.83% | 0.00% | 13.84% | |
手術/内視鏡 +その他 |
1 | 1 | 0 | 0 | 1 | 3 |
1.30% | 5.56% | 0.00% | 0.00% | 10.00% | 1.89% | |
その他の 組み合わせ |
0 | 0 | 0 | 2 | 0 | 2 |
0.00% | 0.00% | 0.00% | 4.88% | 0.00% | 1.26% | |
症状緩和的 治療のみ |
0 | 0 | 1 | 6 | 2 | 9 |
0.00% | 0.00% | 7.69% | 14.63% | 20.00% | 5.66% | |
経過観察 のみ |
4 | 1 | 0 | 6 | 4 | 15 |
5.19% | 5.56% | 0.00% | 14.63% | 40.00% | 9.43% | |
総計 | 77 | 18 | 13 | 41 | 10 | 159 |
100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
大腸がん
0 | I | II | III | IV | 不明・その他 | 総計 | |
---|---|---|---|---|---|---|---|
手術のみ | 15 | 23 | 38 | 16 | 2 | 1 | 95 |
15.15% | 46.00% | 56.72% | 22.22% | 4.17% | 11.11% | 27.54% | |
内視鏡 のみ |
82 | 14 | 0 | 0 | 0 | 0 | 96 |
82.83% | 28.00% | 0.00% | 0.00% | 0.00% | 0.00% | 27.83% | |
手術 +内視鏡 |
0 | 6 | 0 | 0 | 0 | 0 | 6 |
0.00% | 12.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.74% | |
放射線 のみ |
0 | 0 | 1 | 0 | 1 | 0 | 2 |
0.00% | 0.00% | 1.49% | 0.00% | 2.08% | 0.00% | 0.58% | |
薬物療法 のみ |
0 | 0 | 0 | 1 | 4 | 0 | 5 |
0.00% | 0.00% | 0.00% | 1.39% | 8.33% | 0.00% | 1.45% | |
放射線 +薬物 |
0 | 2 | 3 | 5 | 1 | 1 | 12 |
0.00% | 4.00% | 4.48% | 6.94% | 2.08% | 11.11% | 3.48% | |
薬物 +その他 |
0 | 0 | 0 | 1 | 6 | 0 | 7 |
0.00% | 0.00% | 0.00% | 1.39% | 12.50% | 0.00% | 2.03% | |
手術/ 内視鏡 +薬物 |
1 | 1 | 15 | 35 | 22 | 2 | 76 |
1.01% | 2.00% | 22.39% | 48.61% | 45.83% | 22.22% | 22.03% | |
手術/ 内視鏡 +その他 |
0 | 2 | 5 | 3 | 2 | 0 | 12 |
0.00% | 4.00% | 7.46% | 4.17% | 4.17% | 0.00% | 3.48% | |
その他の 組み合 わせ |
0 | 0 | 4 | 6 | 3 | 0 | 13 |
0.00% | 0.00% | 5.97% | 8.33% | 6.25% | 0.00% | 3.77% | |
症状緩和的 治療のみ |
0 | 1 | 0 | 3 | 4 | 3 | 11 |
0.00% | 2.00% | 0.00% | 4.17% | 8.33% | 33.33% | 3.19% | |
経過観察 のみ |
1 | 1 | 1 | 2 | 3 | 2 | 10 |
1.01% | 2.00% | 1.49% | 2.78% | 6.25% | 22.22% | 2.90% | |
総計 | 99 | 50 | 67 | 72 | 48 | 9 | 345 |
100% | 100% | 100% | 100% | 100% | 100% | 100% |
肝がん
I | II | III | IV | 不明・ その他 |
総計 | |
---|---|---|---|---|---|---|
手術のみ | 10 | 4 | 0 | 0 | 0 | 14 |
58.82% | 28.57% | 0.00% | 0.00% | 0.00% | 24.14% | |
放射線 のみ |
0 | 0 | 0 | 1 | 1 | 2 |
0.00% | 0.00% | 0.00% | 7.69% | 14.29% | 3.45% | |
薬物 +その他 |
2 | 2 | 2 | 2 | 2 | 10 |
11.76% | 14.29% | 33.33% | 15.38% | 28.57% | 17.24% | |
手術/ 内視鏡 +薬物 |
0 | 1 | 0 | 0 | 0 | 1 |
0.00% | 7.14% | 0.00% | 0.00% | 0.00% | 1.72% | |
手術/ 内視鏡 +その他 |
0 | 3 | 1 | 1 | 1 | 6 |
0.00% | 21.43% | 16.67% | 7.69% | 14.29% | 10.34% | |
その他の 組み合わせ |
1 | 0 | 1 | 4 | 0 | 6 |
5.88% | 0.00% | 16.67% | 30.77% | 0.00% | 10.34% | |
症状緩和的 治療のみ |
2 | 1 | 1 | 3 | 1 | 8 |
11.76% | 7.14% | 16.67% | 23.08% | 14.29% | 13.79% | |
経過観察 | 2 | 3 | 1 | 2 | 3 | 11 |
11.76% | 21.43% | 16.67% | 15.38% | 42.86% | 18.97% | |
総計 | 17 | 14 | 6 | 13 | 7 | 58 |
100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
肺がん
I | II | III | IV | 不明・ その他 |
総計 | |
---|---|---|---|---|---|---|
手術のみ | 172 | 15 | 12 | 3 | 0 | 202 |
61.43% | 26.79% | 10.26% | 1.48% | 0.00% | 30.42% | |
放射線 のみ |
47 | 8 | 14 | 8 | 2 | 79 |
16.79% | 14.29% | 11.97% | 3.94% | 25.00% | 11.90% | |
薬物療法 のみ |
2 | 0 | 10 | 58 | 0 | 70 |
0.71% | 0.00% | 8.55% | 28.57% | 0.00% | 10.54% | |
放射線 +薬物 |
0 | 2 | 22 | 27 | 0 | 51 |
0.00% | 3.57% | 18.80% | 13.30% | 0.00% | 7.68% | |
薬物 +その他 |
0 | 0 | 3 | 37 | 1 | 41 |
0.00% | 0.00% | 2.56% | 18.23% | 12.50% | 6.17% | |
手術/ 内視鏡 +放射線 |
0 | 1 | 2 | 0 | 0 | 3 |
0.00% | 1.79% | 1.71% | 0.00% | 0.00% | 0.45% | |
手術/ 内視鏡 +薬物 |
49 | 28 | 29 | 10 | 0 | 116 |
17.50% | 50.00% | 24.79% | 4.93% | 0.00% | 17.47% | |
手術/ 内視鏡 +その他 |
0 | 0 | 1 | 0 | 0 | 1 |
0.00% | 0.00% | 0.85% | 0.00% | 0.00% | 0.15% | |
手術/ 内視鏡 +放射線 +薬物 |
0 | 0 | 3 | 0 | 0 | 3 |
0.00% | 0.00% | 2.56% | 0.00% | 0.00% | 0.45% | |
その他の 組み合わせ |
1 | 2 | 14 | 29 | 1 | 47 |
0.36% | 3.57% | 11.97% | 14.29% | 12.50% | 7.08% | |
症状緩和的 治療のみ |
0 | 0 | 2 | 23 | 1 | 26 |
0.00% | 0.00% | 1.71% | 11.33% | 12.50% | 3.92% | |
経過観察 | 9 | 0 | 5 | 8 | 3 | 25 |
3.21% | 0.00% | 4.27% | 3.94% | 37.50% | 3.77% | |
総計 | 280 | 56 | 117 | 203 | 8 | 664 |
100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
乳がん
I | II | III | IV | 総計 | |
---|---|---|---|---|---|
手術のみ | 1 | 2 | 2 | 0 | 5 |
25.00% | 33.33% | 16.67% | 0.00% | 15.15% | |
放射線 のみ |
0 | 0 | 0 | 1 | 1 |
0.00% | 0.00% | 0.00% | 9.09% | 3.03% | |
薬物療法 のみ |
1 | 0 | 1 | 3 | 5 |
25.00% | 0.00% | 8.33% | 27.27% | 15.15% | |
薬物 +その他 |
0 | 0 | 0 | 2 | 2 |
0.00% | 0.00% | 0.00% | 18.18% | 6.06% | |
手術/ 内視鏡 +放射線 |
0 | 2 | 0 | 0 | 2 |
0.00% | 33.33% | 0.00% | 0.00% | 6.06% | |
手術/ 内視鏡 +薬物 |
1 | 2 | 6 | 0 | 9 |
25.00% | 33.33% | 50.00% | 0.00% | 27.27% | |
手術/ 内視鏡 +放射線 +薬物 |
1 | 0 | 2 | 0 | 3 |
25.00% | 0.00% | 16.67% | 0.00% | 9.09% | |
その他の 組み合わせ |
0 | 0 | 0 | 3 | 3 |
0.00% | 0.00% | 0.00% | 27.27% | 9.09% | |
症状緩和的 治療のみ |
0 | 0 | 0 | 2 | 2 |
0.00% | 0.00% | 0.00% | 18.18% | 6.06% | |
経過観察 | 0 | 0 | 1 | 0 | 1 |
0.00% | 0.00% | 8.33% | 0.00% | 3.03% | |
総計 | 4 | 6 | 12 | 11 | 33 |
100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
子宮頸がん
0 | I | II | IV | 不明・ その他 |
総計 | |
---|---|---|---|---|---|---|
手術のみ | 53 | 11 | 0 | 0 | 1 | 65 |
98.15% | 91.67% | 0.00% | 0.00% | 100.00% | 84.42% | |
放射線 +薬物 |
0 | 0 | 4 | 2 | 0 | 6 |
0.00% | 0.00% | 80.00% | 40.00% | 0.00% | 7.79% | |
手術/内視鏡 +放射線 +薬物 |
0 | 1 | 1 | 0 | 0 | 2 |
0.00% | 8.33% | 20.00% | 0.00% | 0.00% | 2.60% | |
その他の 組み合わせ |
0 | 0 | 0 | 3 | 0 | 3 |
0.00% | 0.00% | 0.00% | 60.00% | 0.00% | 3.90% | |
経過観察 | 1 | 0 | 0 | 0 | 0 | 1 |
1.85% | 0.00% | 0.00% | 0.00% | 0.00% | 1.30% | |
総計 | 54 | 12 | 5 | 5 | 1 | 77 |
100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
前立腺がん
I | II | III | IV | 不明・ その他 |
総計 | |
---|---|---|---|---|---|---|
手術のみ | 18 | 127 | 37 | 0 | 0 | 182 |
7.56% | 48.47% | 67.27% | 0.00% | 0.00% | 30.18% | |
内視鏡のみ | 18 | 1 | 1 | 0 | 0 | 20 |
7.56% | 0.38% | 1.82% | 0.00% | 0.00% | 3.32% | |
放射線のみ | 74 | 48 | 0 | 0 | 0 | 122 |
31.09% | 18.32% | 0.00% | 0.00% | 0.00% | 20.23% | |
薬物療法 のみ |
58 | 27 | 6 | 31 | 3 | 125 |
24.37% | 10.31% | 10.91% | 72.09% | 60.00% | 20.73% | |
放射線 +薬物 |
36 | 27 | 1 | 6 | 0 | 70 |
15.13% | 10.31% | 1.82% | 13.95% | 0.00% | 11.61% | |
薬物 +その他 |
0 | 0 | 0 | 2 | 0 | 2 |
0.00% | 0.00% | 0.00% | 4.65% | 0.00% | 0.33% | |
手術/内視鏡 +放射線 |
0 | 0 | 1 | 0 | 0 | 1 |
0.00% | 0.00% | 1.82% | 0.00% | 0.00% | 0.17% | |
手術/内視鏡 +薬物 |
25 | 23 | 9 | 3 | 1 | 61 |
10.50% | 8.78% | 16.36% | 6.98% | 20.00% | 10.12% | |
その他の 組み合わせ |
0 | 0 | 0 | 1 | 0 | 1 |
0.00% | 0.00% | 0.00% | 2.33% | 0.00% | 0.17% | |
経過観察 | 9 | 9 | 0 | 0 | 1 | 19 |
3.78% | 3.44% | 0.00% | 0.00% | 20.00% | 3.15% | |
総計 | 238 | 262 | 55 | 43 | 5 | 603 |
100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |